Physician profile
Rick E Mcclure
NPI 1255432530
$132,600.77
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $512 · 2020: $290 · 2021: $86.27 · 2022: $33K · 2023: $76K · 2024: $22K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $78K · Travel and Lodging: $19K · Food and Beverage: $1,693 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $77,680.00 |
| Travel and Lodging | $19,001.23 |
| Food and Beverage | $1,693.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $131,967.42 | 2020-2024 | |
| Stryker Corporation | $437.37 | 2019-2021 | |
| Djo, LLC | $38.11 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $37.10 | 2019 | |
| Horizon Therapeutics Plc | $33.47 | 2019 | |
| Kci USA, INC. | $28.97 | 2021 | |
| Orthofix Medical, INC. | $18.37 | 2020 | |
| Bioventus LLC | $14.32 | 2021 | |
| Smith+Nephew, INC. | $12.84 | 2021 | |
| Ibsa Pharma INC. | $12.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rick Mcclure listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.